270 related articles for article (PubMed ID: 21138864)
1. New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapies.
Dunleavy K; Piekarz RL; Zain J; Janik JE; Wilson WH; O'Connor OA; Bates SE
Clin Cancer Res; 2010 Dec; 16(23):5608-17. PubMed ID: 21138864
[TBL] [Abstract][Full Text] [Related]
2. Peripheral T-cell lymphomas.
Savage KJ
Blood Rev; 2007 Jul; 21(4):201-16. PubMed ID: 17512649
[TBL] [Abstract][Full Text] [Related]
3. Current management of peripheral T-cell lymphomas.
Gooptu M; Rhoades R; Pro B
Cancer Treat Res; 2015; 165():289-303. PubMed ID: 25655615
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM; Brammer JE
Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic implications of tumor expression of the GATA-3 gene in nodal peripheral T-cell lymphoma (nPTCL): Retrospective data from a Latin American cohort.
de Pádua Covas Lage LA; Brito CV; Levy D; Culler HF; Freitas Couto SC; de Oliveira LBA; Nogueira Zerbini MC; Rocha V; Pereira J
Leuk Res; 2022 Mar; 114():106794. PubMed ID: 35131666
[TBL] [Abstract][Full Text] [Related]
6. Aggressive peripheral T-cell lymphomas (specified and unspecified types).
Savage KJ
Hematology Am Soc Hematol Educ Program; 2005; ():267-77. PubMed ID: 16304391
[TBL] [Abstract][Full Text] [Related]
7. The aggressive peripheral T-cell lymphomas: 2015.
Armitage JO
Am J Hematol; 2015 Jul; 90(7):665-73. PubMed ID: 26031230
[TBL] [Abstract][Full Text] [Related]
8. Frontline Management of Nodal Peripheral T-Cell Lymphomas.
Ngu HS; Savage KJ
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390334. PubMed ID: 37262395
[TBL] [Abstract][Full Text] [Related]
9. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
[TBL] [Abstract][Full Text] [Related]
10. Peripheral T cell lymphoma: Clinico-pathological characteristics & outcome from a tertiary care centre in south India.
Nemani S; Korula A; Agrawal B; Kavitha ML; Manipadam MT; Sigamani E; George B; Srivastava A; Viswabandya A; Mathews V
Indian J Med Res; 2018 May; 147(5):464-470. PubMed ID: 30082570
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of peripheral T-cell lymphomas.
Piccaluga PP; Tabanelli V; Pileri SA
Int J Hematol; 2014 Mar; 99(3):219-26. PubMed ID: 24481943
[TBL] [Abstract][Full Text] [Related]
12. The aggressive peripheral T-cell lymphomas: 2017.
Armitage JO
Am J Hematol; 2017 Jul; 92(7):706-715. PubMed ID: 28516671
[TBL] [Abstract][Full Text] [Related]
13. Update: peripheral T-cell lymphomas.
Savage KJ
Curr Hematol Malig Rep; 2011 Dec; 6(4):222-30. PubMed ID: 21953415
[TBL] [Abstract][Full Text] [Related]
14. T cell and NK cell lymphoproliferative disorders.
Greer JP; Kinney MC; Loughran TP
Hematology Am Soc Hematol Educ Program; 2001; ():259-81. PubMed ID: 11722988
[TBL] [Abstract][Full Text] [Related]
15. Contemporary strategies to improve outcomes for peripheral T-cell lymphoma patients following the failure of first-line therapy.
Kallam A; Armitage JO
Expert Rev Hematol; 2020 Jul; 13(7):745-753. PubMed ID: 32478625
[TBL] [Abstract][Full Text] [Related]
16. Nodal peripheral T-cell lymphoma: Chemotherapy-free management, are we there yet?
Macapagal SC; Bennani NN
Blood Rev; 2023 Jul; 60():101071. PubMed ID: 36898933
[TBL] [Abstract][Full Text] [Related]
17. Treatment selection and survival outcomes in Early-Stage peripheral T-Cell lymphomas: does anaplastic lymphoma kinase mutation impact the benefit of consolidative radiotherapy?
Rodríguez-López JL; Patel AK; Balasubramani GK; Glaser SM; Beriwal S; Vargo JA
Leuk Lymphoma; 2021 Mar; 62(3):538-548. PubMed ID: 33251899
[TBL] [Abstract][Full Text] [Related]
18. Biomarker-driven management strategies for peripheral T cell lymphoma.
Mulvey E; Ruan J
J Hematol Oncol; 2020 May; 13(1):59. PubMed ID: 32448357
[TBL] [Abstract][Full Text] [Related]
19. NK/T-cell lymphomas in children.
Lai C; Dunleavy K
Best Pract Res Clin Haematol; 2013 Mar; 26(1):33-41. PubMed ID: 23768639
[TBL] [Abstract][Full Text] [Related]
20. How to Sequence Therapies in Peripheral T Cell Lymphoma.
Wudhikarn K; Bennani NN
Curr Treat Options Oncol; 2021 Jul; 22(9):74. PubMed ID: 34213653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
